Skip to content
Lifelong-learning — Mental-health — Migration — Nutrition — Cbd — Productivity — Workplace-wellness — Sexual-health — Autoimmune-disorders — Personal-growth — Skin-care — Digestive-health — War-and-conflicts — Hearing — Parenting — general-news — Fitness-and-exercise — Eye-health — Chronic-diseases — Fires — Online-education — Accidents — Mens-health — Skin-conditions — Healthy-diets — Science — Psoriasis — Learning — Weight-management — Health-and-wellness — Crime-and-justice — Type-2-diabetes — Mindfulness — Car-accidents — Politics — Supplements — Family-health — Medicare — Womens-health — Medical-conditions — Aging

International WHO Representative in Russia acknowledges imperfections within the organization, stating it shares similar flaws as other global institutions.

Moscow's closure of the World Health Organization (WHO) office dedicated to preventing non-communicable diseases in 2023 has sparked fears of a complete WHO suspension following the departure of Mopenhophus Wuoyen as Russia's representative.

,   and  Administrator
4 min read

International WHO Representative in Russia acknowledges imperfections within the organization, stating it shares similar flaws as other global institutions.

New and Unfiltered Guide to WHO's Current Activities in Russia

Hey there! Let's take a peek at what the World Health Organization (WHO) is up to these days in Russia.

The Lowdown

The focus of WHO's interaction with Russia primarily revolves around non-communicable diseases and their risk factors, including tobacco, alcohol, low physical activity, and unhealthy diets. Other areas of interest encompass infectious diseases, elderly care, mental health, and antibiotic resistance. As of 2025, the 14th General Programme of Work is being implemented, with a concentration on disease prevention through risk factor interventions, providing quality and affordable healthcare, and ensuring readiness for emergencies.

Collaborating Centers

More than 20 WHO collaborating centers operate in Russia, supporting various programs. A recent addition is a center for geriatrics and elderly care, established in the autumn of 2024. Several other centers are in the works of being designated.

Behind the Scenes in Europe

In the European region, which includes Russia, consultations and the development of a new five-year program (2026-2030) are underway. This will address pressing health issues such as population aging, mental health, health workforce, and AI in healthcare.

Contending with Sanctions

Despite the hurdles posed by the current geopolitical landscape and imposed sanctions, WHO's office in Russia has been operational since 1998. Collaboration through WHO continues to thrive, with active participation in sessions of the World Health Assembly and other governing bodies by the Russian delegation. Russian specialists contribute to various expert working groups, ensuring their country's interests are represented and positive experiences and achievements are shared globally.

The Ruckus Over Generics

There's been quite a stir about the quality of generic medications, with Russian doctors expressing concerns similar to those in China. The WHO maintains that there isn't a generic drug problem as such but a need to ensure the quality, safety, and efficacy of all medications, including generics. The world body is actively combating the spread of substandard and counterfeit medicines.

Bending the Rules: Antibiotic Resistance

Antibiotic resistance is causing significant economic costs, with projections estimating losses of $1 trillion to $3.4 trillion per year in terms of reduced gross domestic product by 2030. Clamping down on antibiotic resistance involves collecting and analyzing data, raising awareness among healthcare workers and the public, and optimizing antibiotic usage. Russia takes part in the Global Antimicrobial Resistance Surveillance System (GLASS) and operates a reference center for monitoring healthcare-associated infections and antibiotic resistance since 2008.

Are Generics Trustworthy?

Yes, according to research, generics are clinically equivalent to branded drugs. To build trust in non-branded drugs, educational efforts regarding generics and strengthening the capacity of regulatory bodies are essential.

Trump's Withdrawal from WHO

The departure of the U.S. from WHO means they'll miss out on global health discussions on WHO platforms and limit access to global databases. The organization continues dialogue at headquarters, hoping that the U.S. will reconsider its decision.

  1. The World Health Organization (WHO) focuses on non-communicable diseases and their risk factors in Russia, such as tobacco, alcohol, low physical activity, and unhealthy diets.
  2. Other areas of interest for WHO in Russia include infectious diseases, elderly care, mental health, and antibiotic resistance.
  3. As of 2025, the 14th General Programme of Work is being implemented, with a concentration on disease prevention through risk factor interventions.
  4. Quality and affordable healthcare and preparedness for emergencies are also key focus areas of the current Programme.
  5. More than 20 WHO collaborating centers operate in Russia, supporting various programs.
  6. A recent addition is a center for geriatrics and elderly care, established in the autumn of 2024.
  7. Several other centers are in the process of being designated.
  8. In the European region, which includes Russia, consultations and the development of a new five-year program (2026-2030) are underway.
  9. This will address issues like population aging, mental health, health workforce, and AI in healthcare.
  10. Despite geopolitical challenges and sanctions, WHO's office in Russia has been operational since 1998.
  11. Collaboration through WHO continues to persist, with active participation in sessions of the World Health Assembly and other governing bodies by the Russian delegation.
  12. Russian specialists contribute to various expert working groups, ensuring their country's interests are represented and positive experiences and achievements are shared globally.
  13. There's been a stir about the quality of generic medications, with Russian doctors expressing concerns similar to those in China.
  14. However, the WHO maintains that there isn't a generic drug problem but a need to ensure the quality, safety, and efficacy of all medications, including generics.
  15. The WHO is actively combating the spread of substandard and counterfeit medicines.
  16. Antibiotic resistance is causing significant economic costs, with estimates showing potential losses of $1 trillion to $3.4 trillion per year in terms of reduced gross domestic product by 2030.
  17. Clamping down on antibiotic resistance involves collecting and analyzing data, raising awareness among healthcare workers and the public, and optimizing antibiotic usage.
  18. Russia participates in the Global Antimicrobial Resistance Surveillance System (GLASS) and operates a reference center for monitoring healthcare-associated infections and antibiotic resistance since 2008.
  19. Generics are clinically equivalent to branded drugs according to research, and building trust in non-branded drugs requires educational efforts and strengthening the capacity of regulatory bodies.
  20. The departure of the U.S. from WHO means they'll miss out on global health discussions on WHO platforms and limit access to global databases.
  21. The organization continues dialogue at headquarters, hoping that the U.S. will reconsider its decision.
  22. Topics covered under WHO's current activities in Russia include chronic diseases, such as type-2 diabetes, respiratory conditions, digestive health, and eye health, among others.
  23. The WHO is also involved in policies related to health and wellness, fitness and exercise, mental health, men's health, skin care, therapies and treatments, nutrition, healthy diets, aging, and women's health, to name a few.
Bilateral agreement: Redact surrenders in cdn-tl9_w7bIudsTZ acknowledging defeat

Read also:

    Related

    Latest